CA2008107A1 - Derives de substitution en 3 ou 4 d'oxotremorine - Google Patents

Derives de substitution en 3 ou 4 d'oxotremorine

Info

Publication number
CA2008107A1
CA2008107A1 CA2008107A CA2008107A CA2008107A1 CA 2008107 A1 CA2008107 A1 CA 2008107A1 CA 2008107 A CA2008107 A CA 2008107A CA 2008107 A CA2008107 A CA 2008107A CA 2008107 A1 CA2008107 A1 CA 2008107A1
Authority
CA
Canada
Prior art keywords
compounds
substituted
oxotremorine
derivatives
oxotremorine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2008107A
Other languages
English (en)
Other versions
CA2008107C (fr
Inventor
Eugene John Trybulski
Richard Hermann Kramss
Herbert Joseph Brabander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2008107A1 publication Critical patent/CA2008107A1/fr
Application granted granted Critical
Publication of CA2008107C publication Critical patent/CA2008107C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
CA002008107A 1989-01-23 1990-01-19 Derives de substitution en 3 ou 4 d'oxotremorine Expired - Fee Related CA2008107C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/300,447 1989-01-23
US07/300,447 US4937235A (en) 1989-01-23 1989-01-23 3- or 4-substituted oxotremorine derivatives

Publications (2)

Publication Number Publication Date
CA2008107A1 true CA2008107A1 (fr) 1990-07-23
CA2008107C CA2008107C (fr) 1996-08-13

Family

ID=23159138

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002008107A Expired - Fee Related CA2008107C (fr) 1989-01-23 1990-01-19 Derives de substitution en 3 ou 4 d'oxotremorine

Country Status (9)

Country Link
US (2) US4937235A (fr)
EP (1) EP0381984B1 (fr)
JP (1) JP2894358B2 (fr)
AT (1) ATE121388T1 (fr)
AU (1) AU622517B2 (fr)
CA (1) CA2008107C (fr)
DE (1) DE69018659T2 (fr)
DK (1) DK0381984T3 (fr)
ES (1) ES2070934T3 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089518A (en) * 1989-01-23 1992-02-18 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives and a method of treating cholinergic dysfunction therewith
JP2834501B2 (ja) * 1989-11-25 1998-12-09 鐘淵化学工業株式会社 3,4―エポキシ酪酸エステルの製法および中間体
US5550257A (en) * 1991-04-24 1996-08-27 American Cyanamid Company Substituted oxotremorine derivatives
US5356885A (en) * 1991-04-24 1994-10-18 American Cyanamid Company Substituted oxotremorine derivatives and pharmaceutical use thereof
US5346910A (en) * 1992-06-03 1994-09-13 American Cyanamid Company Maleimide derivatives of oxotremorine
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245743A (en) * 1967-11-09 1971-09-08 Astra Ab Alkynyl lactams
US3856790A (en) 1970-01-06 1974-12-24 American Home Prod Cyclic amides of 1,4-diaminobut-2-yne
EP0009326A3 (fr) * 1978-08-30 1980-04-16 Pfizer Limited Acides pyrrolyl-2-acétiques, alpha-céto ou alpha-amino, leurs dérivés, méthodes pour leur préparation et compositions pharmaceutiques les contenant
GR78370B (fr) * 1981-12-24 1984-09-26 Delalande Sa
US4847284A (en) * 1988-03-23 1989-07-11 Merck & Co., Inc. Antifungal fermentation product and derivatives and compositions thereof
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
AU622517B2 (en) 1992-04-09
DE69018659D1 (de) 1995-05-24
DK0381984T3 (da) 1995-05-08
CA2008107C (fr) 1996-08-13
EP0381984A1 (fr) 1990-08-16
US4937235A (en) 1990-06-26
AU4868490A (en) 1990-07-26
JP2894358B2 (ja) 1999-05-24
EP0381984B1 (fr) 1995-04-19
DE69018659T2 (de) 1996-01-18
ES2070934T3 (es) 1995-06-16
US4952600A (en) 1990-08-28
JPH02229155A (ja) 1990-09-11
ATE121388T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
TW289020B (fr)
AU6770290A (en) Substituted cyclohexanols as central nervous system agents
HRP940890B1 (en) Novel(r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benozpyranes
SI0852585T1 (en) Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
DE3750733D1 (de) Verfahren zur Herstellung von Hyaluronsäure, dafür benötigte Bakterienstämme und kosmetische Zusammensetzung, welche Hyaluronsäure enthält.
CS38989A2 (en) Method of phenoxyacetamidoderivative production
DK314487A (da) Benzoxepinderivat
HUT45960A (en) Process for producing 2,4,5-trisubstituted derivatives of phenol of antiflogistic activity
WO1990000853A8 (fr) Procede pour traiter des troubles neurologiques
EP0167909A3 (en) Solid pharmaceutical preparations containing dihydropyridines, and process for their manufacture
CA2008107A1 (fr) Derives de substitution en 3 ou 4 d'oxotremorine
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
AU6770190A (en) Substituted cyclohexenes as central nervous system agents
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
NZ225660A (en) Individual optical isomers of 2-methylspiro-(1,3-oxathiolan-5,3')-quinuclidine, and pharmaceutical compositions containing such
HUT45967A (en) Process for production of antipasmodic derivatives of n-/substituated phenil/-benzoil-amid
AU565799B2 (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
ZA898274B (en) 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments
CS39189A2 (en) Method of tetrahydropyridine derivatives production
PT93822A (pt) Processo para a preparacao de derivados de piridina

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed